Impact of a Multisensory Clinical Environment on Pain and Patient Experience During Office Hysteroscopy: The VISION-HYST Randomized Controlled Pilot Trial
Clinical and Experimental Obstetrics & Gynecology · 22.07.2026 · 53 (7)
DOI: 10.31083/ceog53148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 22.07.2026. Verfasst von Alessandro Messina und 11 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background:Pain and anxiety remain major barriers to the tolerability and widespread adoption of office hysteroscopy, despite advances in minimally invasive techniques and the use of nitrous oxide (N2O) analgesia. Non-pharmacological interventions targeting the clinical environment may offer a complementary strategy to improve patient experience. To evaluate the preliminary effect of a multisensory clinical setting, incorporating visual environmental distraction, on pain perception during operative office hysteroscopy.Methods:This randomized, parallel-group pilot trial enrolled 50 women undergoing operative office hysteroscopy in an outpatient setting. Participants were allocated to standard care with N2O (control group) or N2O combined with a multisensory intervention consisting of a wall-mounted virtual window displaying relaxing visual content (intervention group). The primary outcome was procedural pain assessed on a 10-point scale. Secondary outcomes included referral to the operating room and procedural feasibility. Between-group differences were analyzed using Welch’s t-test.Results:50 patients were randomized (25 per group), and all completed the study. Mean pain scores were significantly lower in the intervention group than in the control group (3.1 ± 1.5 vs. 5.8 ± 1.9; p < 0.001). The reduction in pain was observed across different hysteroscopic techniques and appeared more pronounced among multiparous women. No significant between-group differences were observed in secondary outcomes, including referral to the operating room (20% vs. 12%; p = 0.702). No adverse events related to the intervention or N2O were reported.Conclusions:In this pilot randomized trial, the addition of a simple visual environmental distraction to standard N2O analgesia was associated with reduced pain during operative office hysteroscopy. These findings suggest that non-pharmacological, environment-based strategies may complement existing analgesic approaches to enhance patient experience. Larger, adequately powered studies are needed to confirm these preliminary findings.Clinical Trial Registration:This study is registered on the ClinicalTrials.gov (registration number: NCT07473206).
Zitieren
APA
Messina, A., Libretti, A., Alessi, P., Lipari, G., Parpinel, G., Chimenti, C., Valloreo, F., Bruno, T., Vegro, S., Thomasset, R., Leo, L., & Masturzo, B. (2026). Impact of a Multisensory Clinical Environment on Pain and Patient Experience During Office Hysteroscopy: The VISION-HYST Randomized Controlled Pilot Trial. Clinical and Experimental Obstetrics & Gynecology, 53(7). https://doi.org/10.31083/ceog53148
Vancouver
Messina A, Libretti A, Alessi P, Lipari G, Parpinel G, Chimenti C, et al. Impact of a Multisensory Clinical Environment on Pain and Patient Experience During Office Hysteroscopy: The VISION-HYST Randomized Controlled Pilot Trial. Clinical and Experimental Obstetrics & Gynecology. 2026;53(7). doi:10.31083/ceog53148
BibTeX
@article{Messina2026,
author = {Messina, Alessandro and Libretti, Alessandro and Alessi, Paolo and Lipari, Giovanni and Parpinel, Giulia and Chimenti, Camilla and Valloreo, Francesca and Bruno, Tiziana and Vegro, Sofia and Thomasset, Raphael and Leo, Livio and Masturzo, Bianca},
title = {Impact of a Multisensory Clinical Environment on Pain and Patient Experience During Office Hysteroscopy: The VISION-HYST Randomized Controlled Pilot Trial},
journal = {Clinical and Experimental Obstetrics & Gynecology},
year = {2026},
volume = {53},
number = {7},
doi = {10.31083/ceog53148}
}
EUVIMED